Left Menu
Development News Edition

Glenmark Q3 net profit rises 64 pc to Rs 190.83 cr; to raise USD 400 mn

Glenmark Q3 net profit rises 64 pc to Rs 190.83 cr; to raise USD 400 mn

Drug firm Glenmark Pharmaceuticals on Friday reported a 64.02 per cent jump in its consolidated net profit to Rs 190.83 crore for the quarter ended December 31, 2019, mainly on account of robust sales in the Indian market. Its board also approved raising of funds up to USD 400 million (over Rs 2,855 crore) through issuance of securities.

The company had posted a net profit of Rs 116.34 crore in the corresponding period of the previous financial year, Glenmark Pharmaceuticals said in a filing to the BSE. The firm's board has approved the "raising of funds up to USD 400 million by either by issuance of bonds / debentures / non-convertible debt instruments or any other securities or any combination thereof, of any of the above, for refinancing of bonds/FCCBs/loans...," Glenmark said.

Consolidated revenue of the company stood at Rs 2,735.56 crore for the quarter under consideration as against Rs 2,555.04 crore for the corresponding period a year ago. "While the US business lost some of its momentum in the third quarter, the India business continued to grow at a healthy pace, consistently outperforming industry growth. We expect the ROW (Rest of the World) region and the European business to gain traction in the coming few quarters," Glenmark Pharmaceuticals Chairman and MD Glenn Saldanha said.

Despite the challenging macroeconomic environment globally, the company still continued to record high single-digit revenue growth and "we hope that we can consistently grow the business every year", he added. Sales from the formulation business in India stood at Rs 788.83 crore for the third quarter ended December 31, 2019, as against Rs 667.53 crore in the previous corresponding quarter, recording a growth of 18.17 per cent, Glenmark said.

Glenmark Pharmaceuticals Inc USA registered revenue from sale of finished dosage formulations of Rs 799.82 crore for the quarter ended December 31, 2019, as against a revenue of Rs 855.67 for the previous corresponding quarter, recording a de-growth of 6.53 per cent, it added. Shares of Glenmark Pharmaceuticals on Friday closed at Rs 333.65 per scrip on the BSE, up 1.83 per cent from its previous close.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Download The Devdiscourse News App for Latest News.



Conspiracy theories on COVID 19: Legislators, Scientists, and Journalists all joined the Caravan

Conspiracy theories are not new for virus epidemics. There have been conspiracy theories on HIV-AIDS, Polio Vaccines, Ebola Virus, and several other diseases as well. However, what makes the 2019 Novel Coronavirus different from others is ...

Top 10 Fake News, Myths and Realities on 2019 Novel Coronavirus COVID 19

With nearly 1500 deaths by January 14 and around 65,000 infections in China, the Novel Coronavirus 2019 has become one of the worst health epidemics of the 21st Century. However, 8,573 people have been cured but the rumor mongers are a...

Handling fake news Infodemic in time of Coronavirus epidemic

Social media has provided a platform where everybody can disseminate his her views without any supervision. Its excellent if the message is genuine but misinformation is equally disastrous. Health is such a topic where every Tom and Harry c...

Sentiment Analysis on Budget 2020: Long shot for solution to economic worries?

Industries and individuals alike had high expectations from the government to take tangible steps but the budget 2020 seems to have failed expectations....


Latest News

UPDATE 10-Suspected shisha bar gunman published racist manifesto

A man suspected of shooting dead nine people in shisha bars in a German town before killing himself and his mother had posted a manifesto online including conspiracy theories and deeply racist views, prosecutors said on Thursday.The presume...

I won't let down French fishermen in Brexit talks, says Macron

French President Emmanuel Macron said on Thursday that he will not let down French fishermen in post-Brexit trade negotiations and that France will seek compensation if it doesnt get the same access to British waters as before. British fish...

'Inconspicuous' German shooting suspect kept racist views under wraps

A man accused of mounting one of post-war Germanys worst racist attacks was described on Thursday as an inconspicuous trained bank clerk who gave few public signs of the views he was quietly recording in a 24-page manifesto.The 43-year-old ...

UPDATE 1-Tennis-Rybakina downs Pliskova to reach Dubai semis, Muguruza out

Kazakhstans Elena Rybakina produced another upset by beating second seed Karolina Pliskova 7-61 6-3 at the Dubai Duty Free Tennis Championships on Thursday to move into the semi-finals.Having knocked out Australian Open champion Sofia Kenin...

Give Feedback